During the past decade, Jose Navarro Partida conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Jose Navarro Partida" are "Dry Eye" (1 trials) and "Glaucoma" (1 trials). Many other conditions were trialed in "Jose Navarro Partida" in a lesser frequency.

Most popular intervention types in "Jose Navarro Partida" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Nanodrop®" (1 trials), "PRO 179" (1 trials), "Systane Balance" (1 trials) and "Travatan 0.004 % Ophthalmic Solution" (1 trials). Other intervention names were less common.

The vast majority of trials in "Jose Navarro Partida" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Jose Navarro Partida". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Jose Navarro Partida, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Jose Navarro Partida, 2 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".